PARP4 deficiency enhances sensitivity to ATM inhibitor by impairing DNA damage repair in melanoma

Abstract Besides the important pathogenic mechanisms of melanoma, including BRAF-driven and immunosuppressive microenvironment, genomic instability and abnormal DNA double-strand breaks (DSB) repair are significant driving forces for its occurrence and development. This suggests investigating novel...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuehua Li, Yu Liu, Jingjing Ma, Yuqi Yang, Qiao Yue, Guannan Zhu, Weinan Guo, Tianwen Gao, Qiong Shi, Chunying Li
Format: Article
Language:English
Published: Nature Publishing Group 2025-01-01
Series:Cell Death Discovery
Online Access:https://doi.org/10.1038/s41420-025-02296-0
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571999471271936
author Yuehua Li
Yu Liu
Jingjing Ma
Yuqi Yang
Qiao Yue
Guannan Zhu
Weinan Guo
Tianwen Gao
Qiong Shi
Chunying Li
author_facet Yuehua Li
Yu Liu
Jingjing Ma
Yuqi Yang
Qiao Yue
Guannan Zhu
Weinan Guo
Tianwen Gao
Qiong Shi
Chunying Li
author_sort Yuehua Li
collection DOAJ
description Abstract Besides the important pathogenic mechanisms of melanoma, including BRAF-driven and immunosuppressive microenvironment, genomic instability and abnormal DNA double-strand breaks (DSB) repair are significant driving forces for its occurrence and development. This suggests investigating novel therapeutic strategies from the synthetic lethality perspective. Poly (ADP-ribose) polymerase 4 (PARP4) is known to be a member of the PARP protein family. The low expression of PARP4 is significantly associated with defective DSB repair markers and poor prognosis in melanoma. Further research revealed that PARP4 plays a role in DSB repair by regulating the non-homologous end joining (NHEJ) pathway through its involvement in Ku80 mono-ADP-ribosylation. Moreover, from a synthetic lethality perspective, PARP4 expression is associated with ATM inhibitor sensitivity. Overall, our study provides new and valuable insights into the function of PARP4 and melanoma pathogenesis and suggests that ATM inhibitor may be a promising therapeutic approach for treating melanoma with low PARP4 expression.
format Article
id doaj-art-4fbe62a3454b40198521f7280b934e63
institution Kabale University
issn 2058-7716
language English
publishDate 2025-01-01
publisher Nature Publishing Group
record_format Article
series Cell Death Discovery
spelling doaj-art-4fbe62a3454b40198521f7280b934e632025-02-02T12:08:44ZengNature Publishing GroupCell Death Discovery2058-77162025-01-0111111110.1038/s41420-025-02296-0PARP4 deficiency enhances sensitivity to ATM inhibitor by impairing DNA damage repair in melanomaYuehua Li0Yu Liu1Jingjing Ma2Yuqi Yang3Qiao Yue4Guannan Zhu5Weinan Guo6Tianwen Gao7Qiong Shi8Chunying Li9Department of Dermatology, Xijing Hospital, Fourth Military Medical UniversityDepartment of Dermatology, Xijing Hospital, Fourth Military Medical UniversityDepartment of Dermatology, Xijing Hospital, Fourth Military Medical UniversityDepartment of Dermatology, Xijing Hospital, Fourth Military Medical UniversityDepartment of Dermatology, Xijing Hospital, Fourth Military Medical UniversityDepartment of Dermatology, Xijing Hospital, Fourth Military Medical UniversityDepartment of Dermatology, Xijing Hospital, Fourth Military Medical UniversityDepartment of Dermatology, Xijing Hospital, Fourth Military Medical UniversityDepartment of Dermatology, Xijing Hospital, Fourth Military Medical UniversityDepartment of Dermatology, Xijing Hospital, Fourth Military Medical UniversityAbstract Besides the important pathogenic mechanisms of melanoma, including BRAF-driven and immunosuppressive microenvironment, genomic instability and abnormal DNA double-strand breaks (DSB) repair are significant driving forces for its occurrence and development. This suggests investigating novel therapeutic strategies from the synthetic lethality perspective. Poly (ADP-ribose) polymerase 4 (PARP4) is known to be a member of the PARP protein family. The low expression of PARP4 is significantly associated with defective DSB repair markers and poor prognosis in melanoma. Further research revealed that PARP4 plays a role in DSB repair by regulating the non-homologous end joining (NHEJ) pathway through its involvement in Ku80 mono-ADP-ribosylation. Moreover, from a synthetic lethality perspective, PARP4 expression is associated with ATM inhibitor sensitivity. Overall, our study provides new and valuable insights into the function of PARP4 and melanoma pathogenesis and suggests that ATM inhibitor may be a promising therapeutic approach for treating melanoma with low PARP4 expression.https://doi.org/10.1038/s41420-025-02296-0
spellingShingle Yuehua Li
Yu Liu
Jingjing Ma
Yuqi Yang
Qiao Yue
Guannan Zhu
Weinan Guo
Tianwen Gao
Qiong Shi
Chunying Li
PARP4 deficiency enhances sensitivity to ATM inhibitor by impairing DNA damage repair in melanoma
Cell Death Discovery
title PARP4 deficiency enhances sensitivity to ATM inhibitor by impairing DNA damage repair in melanoma
title_full PARP4 deficiency enhances sensitivity to ATM inhibitor by impairing DNA damage repair in melanoma
title_fullStr PARP4 deficiency enhances sensitivity to ATM inhibitor by impairing DNA damage repair in melanoma
title_full_unstemmed PARP4 deficiency enhances sensitivity to ATM inhibitor by impairing DNA damage repair in melanoma
title_short PARP4 deficiency enhances sensitivity to ATM inhibitor by impairing DNA damage repair in melanoma
title_sort parp4 deficiency enhances sensitivity to atm inhibitor by impairing dna damage repair in melanoma
url https://doi.org/10.1038/s41420-025-02296-0
work_keys_str_mv AT yuehuali parp4deficiencyenhancessensitivitytoatminhibitorbyimpairingdnadamagerepairinmelanoma
AT yuliu parp4deficiencyenhancessensitivitytoatminhibitorbyimpairingdnadamagerepairinmelanoma
AT jingjingma parp4deficiencyenhancessensitivitytoatminhibitorbyimpairingdnadamagerepairinmelanoma
AT yuqiyang parp4deficiencyenhancessensitivitytoatminhibitorbyimpairingdnadamagerepairinmelanoma
AT qiaoyue parp4deficiencyenhancessensitivitytoatminhibitorbyimpairingdnadamagerepairinmelanoma
AT guannanzhu parp4deficiencyenhancessensitivitytoatminhibitorbyimpairingdnadamagerepairinmelanoma
AT weinanguo parp4deficiencyenhancessensitivitytoatminhibitorbyimpairingdnadamagerepairinmelanoma
AT tianwengao parp4deficiencyenhancessensitivitytoatminhibitorbyimpairingdnadamagerepairinmelanoma
AT qiongshi parp4deficiencyenhancessensitivitytoatminhibitorbyimpairingdnadamagerepairinmelanoma
AT chunyingli parp4deficiencyenhancessensitivitytoatminhibitorbyimpairingdnadamagerepairinmelanoma